Opko Health Inc is a diverse healthcare company that operates globally, offering a mix of diagnostic and pharmaceutical services. It runs BioReference Laboratories, providing a wide range of laboratory testing services to detect and monitor diseases. Opko also develops and markets pharmaceuticals, including treatments for chronic kidney disease, secondary hyperparathyroidism, type 2 diabetes, and obesity. Additionally, it focuses on creating immune therapies for oncology and infectious diseases, alongside developing long-acting versions of approved therapeutic proteins. Founded in 1991, Opko is based in Miami, Florida, with operations in several countries.
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
Insider buying was somewhat slow in the middle of January, but some purchases by Warren Buffett's Berkshire Hathaway made headlines.
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
